CRIS Current Research Information System

BOVE, MARILISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.696
EU - Europa 1.279
AS - Asia 346
AF - Africa 99
SA - Sud America 6
OC - Oceania 2
Totale 3.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.695
GB - Regno Unito 384
DE - Germania 217
SE - Svezia 166
IT - Italia 156
CN - Cina 142
IN - India 88
UA - Ucraina 80
VN - Vietnam 78
IE - Irlanda 67
FR - Francia 57
CI - Costa d'Avorio 45
RU - Federazione Russa 39
EE - Estonia 30
JO - Giordania 27
ZA - Sudafrica 25
TG - Togo 23
BG - Bulgaria 21
CH - Svizzera 18
GR - Grecia 10
ES - Italia 6
RO - Romania 6
SC - Seychelles 6
CL - Cile 5
AT - Austria 4
BE - Belgio 4
PL - Polonia 4
TR - Turchia 4
NL - Olanda 3
AU - Australia 2
FI - Finlandia 2
HK - Hong Kong 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CA - Canada 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
Totale 3.428
Salva come PNG Salva come JPEG
Città #
Southend 352
Fairfield 246
Ashburn 138
Chandler 137
Woodbridge 128
Seattle 104
Houston 99
Wilmington 94
Princeton 93
Cambridge 91
Ann Arbor 67
Dublin 66
Dong Ket 60
Turin 46
Abidjan 45
Jacksonville 45
Westminster 39
Berlin 35
Nanjing 32
Padova 30
Bremen 28
Amman 27
Lomé 23
Sofia 21
Bologna 18
Hebei 18
Dearborn 17
Saint Petersburg 17
Bern 16
Jinan 15
San Diego 14
Nanchang 13
Des Moines 11
Shenyang 10
Los Angeles 9
Medford 8
Milan 8
Changsha 7
Olalla 7
Taizhou 7
Beijing 6
Paris 6
Redwood City 6
Bühl 5
Falls Church 5
Jiaxing 5
Mahé 5
Mountain View 5
Brussels 4
Ningbo 4
Rome 4
San Venanzo 4
Santiago 4
Barcelona 3
Boardman 3
Chicago 3
Groningen 3
Karditsa 3
Kayseri 3
London 3
Redmond 3
Tianjin 3
Verona 3
Zhengzhou 3
Boydton 2
Buffalo 2
Florence 2
Frankfurt Am Main 2
Haikou 2
Hangzhou 2
Hefei 2
Kuban 2
Kuehnsdorf 2
Kunming 2
Lahore 2
Lanzhou 2
Melbourne 2
Moscow 2
Mülheim 2
New York 2
Norwalk 2
Provo 2
Pune 2
San Bonifacio 2
Shanghai 2
Taiyuan 2
Wirral 2
Athens 1
Bareggio 1
Basra 1
Beach Lake 1
Bergamo 1
Boulder 1
Cagliari 1
Castel Maggiore 1
Costa Mesa 1
Delhi 1
Dubai 1
Easton 1
Edinburgh 1
Totale 2.396
Salva come PNG Salva come JPEG
Nome #
null 131
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 127
Sources of variabilità of plasma HDL-cholesterol levels. 108
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia 105
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 104
null 98
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 95
null 93
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 91
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 88
Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial 88
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 87
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 85
null 82
Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation 80
Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome. 78
null 75
null 75
Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale 74
null 73
null 71
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial 69
null 68
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 68
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. 68
Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial 67
Role of olive oil in the health: results form the Eurolive Study. 66
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 65
null 64
Emerging drugs for the treatment of hypercholesterolemia 63
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 62
null 62
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 56
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 56
Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia. 56
Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia. 54
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 54
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial 53
null 51
Efficacy and safety of Armolipid Plus®: an updated PRISMA compliant systematic review and meta-analysis of randomized controlled clinical trials. 46
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. 44
Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. 43
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 39
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 38
Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular Disease 37
Successful treatment of a patient with mitochondrial myopathy with alirocumab 35
Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection 35
Effect of a sequential training program on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome 33
Evaluation of the short term efficacy and tolerability of a combined nutraceutical with lipid lowering properties: a randomized clinical trial. 31
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. 27
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. 27
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approach 21
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 17
The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function 16
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial 11
Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia 10
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product 8
Sources of variability of plasma HDL-cholesterol levels. 4
MMP-2, MMP-9 and their inhibitors and other prothrombotic risk factors plasma level in FCH, MS, FCH plus MS and control subjects 3
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate 1
CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING 1
Prevalence of Hypo- and Hyperalphalipoproteinemia according to different diagnostic criteria in the massa lombarda project cohort 1
Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT 1
EFFECT OF QUANTITATIVE AND QUALITATIVE DIET PRESCRIPTION ON CHILDREN BEHAVIOUR AFTER A DIAGNOSIS OF FAMILIAL DYSLIPIDEMIA 1
NUTRACEUTICAL EFFECTS ON GLUCOSE AND LIPID METABOLISM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: A PILOT, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL 1
Totale 3.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019101 0 0 0 0 0 0 0 0 0 41 10 50
2019/2020950 138 25 10 45 91 102 118 141 120 81 28 51
2020/2021470 122 29 18 22 4 27 13 27 52 37 24 95
2021/2022737 73 17 40 26 83 50 9 37 38 24 214 126
2022/2023867 66 99 25 140 57 53 34 43 192 37 84 37
2023/2024191 5 46 20 26 15 34 12 21 2 10 0 0
Totale 3.541